Applying a test system for discriminating fetal from maternal cells

Prenatal Diagnosis

Volumn 23, Issue 8, 2003, Pages 619-624

  Bayrak Toydemir, Pinar ^a   Pergament, Eugene ^a   Fiddler, Morris ^a,b  

^a Reprogenetics Research Inc   (United States)

^b DEPAUL UNIVERSITY   (United States)

Author keywords

CD71; Epsilon globin; Fetal cell detection; Flk 1; Immunohistochemistry

Indexed keywords

CD71 ANTIGEN; CELL MARKER;

ANALYTIC METHOD; ARTICLE; CENTRIFUGATION; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC TEST; FETUS; FETUS BLOOD SAMPLING; FETUS CELL; FLUORESCENCE IN SITU HYBRIDIZATION; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; X CHROMOSOME; Y CHROMOSOME;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; BIOLOGICAL MARKERS; CELL SEPARATION; CHORIONIC VILLI SAMPLING; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; FETAL BLOOD; FETUS; GESTATIONAL AGE; GLOBINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PREGNANCY; RECEPTORS, TRANSFERRIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 0042522847     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.656     Document Type: Article

References (14)

1. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides K. 2001. Distribution of fetal and embryonic hemoglobins in fetal erythroblasts enriched from maternal blood. Haematologica 86: 357-362.
2. Bayrak-Toydemir P, Fiddler MB, Pergament E. 2002. Simplifying fetal cell analysis in maternal circulation. Am J Hum Genet 71: suppl 2311.
3. Bianchi DW, Klinger KW, Vadnais TJ, et al. 1996. Development of a model system to compare cell separation methods for the isolation of fetal cells from maternal blood. Prenat Diagn 16(4): 289-298.
4. Choolani M, O'Donnell H, Campagnoli C, et al. 2001. Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization. Blood 98(3): 554-557.
5. Ganshirt D, Smeets FW, Dohr A, et al. 1998. Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: experiences with triple density gradient and MACS based on more than 600 cases. Fetal Diagn Ther 13(5): 276-286.
6. Hohmann H, Michel S, Reiber W, Gunther M, Claussen U, von Eggeling F. 2001. Applicability of four new antibodies for the detection of fetal nucleated cells out of maternal blood by FISH analysis. Fetal Diagn Ther 16: 52-56.
7. Jakobs ME, van Lith JMM, Graaf IM, Knegt AC, Hoovers JMN. 2000. Genetic analysis of fetal nucleated red blood cells from CVS washings. Prenat Diagn 20: 832-834.
8. Jansen MW, von Lindern M, Beug H, et al. 1999. The use of in vitro expanded erythroid cells in a model system for the isolation of fetal cells from maternal blood. Prenat Diagn 19(4): 323-329.
9. Kabrun N, Buhring HJ, Choi K, Ullrich A, Risau W, Keller G. 1997. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124(10): 2039-2048.
10. Peschle C, Mavilio F, Care A, et al. 1985. Haemoglobin switching in human embryos: a synchrony of zeta-alfa and epsilon-gama-globin switches in primitive and definite erythropoietic lineage. Nature 313: 235-238.
11. Quinn TP, Peters KG, Vries C, Ferrara N, Williams LT. 1993. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537.
12. Thilaganathan B, Meher Homji NJ, Stagiannis K, Nicolaides KH. 1993. Transferrin receptor expression in fetal blood mononuclear cells. Br J Obstet Gynaecol 100: 395-396.
13. Voullaire L, Ioannou P, Nouri S, Williamson R. 2001. Fetal nucleated red blood cells from CVS washings: an aid to development of first trimester non-invasive prenatal diagnosis. Prenat Diagn 21: 827-834.
14. Zheng YL, Zhen DK, DeMaria MA, et al. 1997. Search for the optimal fetal cell antibody: results of immunophenotyping studies using flow cytometry. Hum Genet 100: 35-42.